AngioDynamics ANGO Change in Fair Value of Contingent Consideration
Change in Fair Value of Contingent Consideration at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:ChangeInFairValueOfContingentConsideration.
The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's change in fair value of contingent consideration?
- AngioDynamics (ANGO) reported change in fair value of contingent consideration of $68K in Q1 2025.
- How has AngioDynamics's change in fair value of contingent consideration changed year-over-year?
- AngioDynamics's change in fair value of contingent consideration decreased by 37.0% year-over-year, from $108K to $68K.
- What is the long-term trend for AngioDynamics's change in fair value of contingent consideration?
- Over 4 years (2021 to 2025), AngioDynamics's change in fair value of contingent consideration has grown at a 32.2% compound annual growth rate (CAGR), from $89K to $272K.
- What does change in fair value of contingent consideration mean?
- This reflects non-cash adjustments to the estimated liability for future payments owed to sellers of acquired businesses. Changes in this value are driven by the performance of the acquired entity relative to pre-defined earn-out targets. It serves as an indicator of whether acquired assets are meeting or exceeding their projected financial milestones.